Fungal infections after liver transplantation by Kusne, S et al.
Fungal Infecti9ns After Liver Transplantation 
S. Kusne. J.S. Dummer. N. Singh. L. Makowka. C. Esquivel. T.E. Starzl. and M. Ho 
A STUDY DONE at our institution between 1981 and 1983 showed that 
42% of liver recipients developed invasive fun-
gal infections, mostly due to Candida and 
Aspergillus. l Between July 1984 and Septem-
ber 1985 we studied 101 consecutive adult 
liver transplant recipients at Presbyterian 
University Hospital for the incidence and risk 
factors associated with invasive fungal infec-
tion. The risk factors that were analyzed 
included age, sex, underlying liver diagnosis, 
clinical status and laboratory values before 
transplantation, antibiotic use before and 
after surgery, total surgical time and number 
of laparotomies, immunosuppression, and the 
amount of blood products used. 
METHODS 
The patients included in this study were 39 men and 62 
women who were followed prospectively for fungal infec-
tions after orthotopic liver transplantation using either a 
choledochocholedochostomy or a choledochojejunostomy. 
Venovenous bypass was used routinely.2 
All patients received antibiotic prophylaxis with ampi-
cillin and cefotaxime at 4 g/ d each for five consecutive 
days after surgery. Nystatin (Mycostatin) (400,000 units 
four times daily) was used orally for candida prophylaxis. 
The immunosupressive agents used were cyclosporine 
(CsA) and corticosteroids. Azathioprine was used to 
allow the use of a lower dose of CyA. A high dose of oral 
or intravenous (IV) steroids and OKT3 were used for the 
treatment of acute rejection. 
Criteria for the diagnosis of invasive fungal infections 
were any of the following: (I) a positive blood culture, (2) 
a positive culture from an ordinarily sterile site (peritone-
um, pleural cavity, etc). or (3) demonstration of tissue 
invasion by biopsy or at autopsy. Simple candida cystitis 
and oral thrush were excluded. 
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Proportions were analyzed by chi-square. and means 
were compared with Student's t test. 
RESULTS 
The patients were followed for a mean of 
394 days. There were 14 episodes of invasive 
candida infections in 13 patients and 4 cases 
of invasive aspergillosis in four patients. Over-
all, 16 (16%) patients developed an invasive 
fungal infection. Ten (77%) of 13 patients 
with candida infection and all four patients 
with aspergillosis died. Five (31%) of 16 
patients were diagnosed at postmortem exam-
ination. These had not been treated with 
amphotericin B. All cases occurred within 2 
months of liver transplantation, and 67% of 
the cases occurred in the first month after a 
transplant operation. No significant differ-
ence was found between sex, age, underlying 
diagnosis, and the frequency of invasive fun-
gal infections. Other variables that did not 
correlate with an increased rate of invasive 
fungal infection were: the use of steroids and 
intravenous antibiotics in the month before 
transplantation, presence of ascites, gastroin-
testinal bleeding or encephalopathy, positivity 
for hepatitis B surface antigen, and presence 
of a thrombosed portal vein or a biliary drain. 
All patients with invasive fungal infections 
spent more than the median number of hours 
(12 hours) of cumulative time in the operating 
room (P < .001, t test). A similar correlation 
was found between invasive fungal infections 
and number of laparotomies performed. 
Patients who had only one transplant opera-
tion and no subsequent abdominal operations 
had a significantly lower rate of invasive fun-
gal infections than other patients in terms of 
episodes per patient (EjP) (0.04 EjP v 0.45 
EjP, P < .001). 
There was a trend toward a higher rate of 
invasive fungal infection in patients r~iving " 
OKT3 monoclonal antibody for rejeCtion 
(0.24 EjP v 0.08 EjP, .05 < P < .1). Invasive 
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fungal infections were significantly more fre-
quent in the patients who received nonprophy-
lactic IV antibiotics for more than the median 
(5) number of days (2.02 E/P v 0.68 E/P; 
p < .001). A correlation was found also 
between the use of a greater number of units 
of RBCs and fresh-frozen plasma, during the 
transplant admission (both comparisons, 0.29 
E/P v 0.06 E/P; P < .01). 
The following pretransplant laboratory 
findings were significantly correlated with 
fungus infections. All patients with fungal 
infections had thrombocytopenia (platelet 
count less than 1RMIMMM/~iFK More fungal 
infections were diagnosed in patients with 
laboratory values below the following medians 
for the group: a T lymphocyte count less than 
536, a CD4 helper cell count less than 390, a T 
helper IT suppressor cell ratio less than 2.8, 
and a serum IgA level less than 360 mg/dL. 
DISCUSSION AND CONCLUSIONS 
The rate of invasive fungal infections in this 
series (16%) was significantly decreased com-
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pared with the 42% of our 1981 to 1983 
study, l probably because of better CsA moni-
toring, better surgical techniques, and the 
institution of venous bypass during surgery.2 
Fungal infections, however, were still an 
important cause of morbidity and mortality 
after liver transplantation. The risk factors for 
development of invasive fungal infections 
after liver transplantation were (1) longer 
duration of treatment with nonprophylactic 
IV antibiotics, (2) longer cumulative surgical 
time and a higher number of laparotomies, (3) 
an increased number of units of RBCs and 
fresh-frozen plasma, and (4) a series of pre-
transplant laboratory findings: thrombocyto-
penia, low T lymphocyte levels, low CD4 
helper cell and lower helper I suppressor cell 
ratios and IgA serum levels. The significance 
of some of these findings is still unclear. 
Attention to the risk factors outlined earlier 
may aid both in preventing and in the early 
detection of invasive fungal infections after 
liver transplantation. 
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